PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportssurgical wound infection
MeSH D013530 - surgical wound infection
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D011183:Postoperative complications
$
Success rate
D014946:Wound infection
$
Success rate
D013530: 
Surgical wound infection
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Abbott BiotherapeuticsMetronidazole Metronidazole  1983-11-18   
Able LaboratoriesMetronidazole Metronidazole  2003-06-25   
Alcon ResearchPovidone-iodine Betadine  1986-12-17   
Alembic PharmaceuticalsMetronidazole Metronidazole  2009-06-23   
Alkem LaboratoriesCefuroxime axetil Cefuroxime Axetil  2010-06-07   
Cephalexin Cephalexin  2010-12-20   
Allegiance HealthcarePovidone-iodine Povidone  1989-03-31   
AllerganAmpicillin Ampicillin  1988-10-24   
Cefuroxime Cefuroxime  1993-02-26   
Metronidazole Metronidazole  1984-12-20   
Amneal PharmaceuticalsMetronidazole Metronidazole  2023-05-24   
ANDA RepositoryCefuroxime axetil Cefuroxime Axetil  2008-02-15   
Cephalexin Cephalexin  2005-06-28   
1
2
3
4
5
6
...
9
>
Clinical Trials
Historical Success Rate
Phase 1
56%
5/9
Phase 2
80%
12/15
Phase 3
65%
24/37
Approved: 11Overall Success rate: 29%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abbott Biotherapeutics
Aclaris Therapeutics
1
2
3
4
5
6
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use